The propionic acids represent the largest chemical class of nonsteroidal anti-inflammatory agents (NSAID). Several of them are widely used, both in the United States and internationally. This paper discusses observations made on fenoprofen, flurbiprofen, ibuprofen and naproxen. Of these compounds, three are racemates; the fourth, naproxen, is an enantiomer. As a group, the propionic acids, along with most members of the other classes of NSAID, produce gastrointestinal damage in most species. These lesions vary from erythema, hemorrhage and erosion to ulceration and peritonitis. As might be expected, the degree of gastrointestinal intolerance depends on many factors: the individual compound, the dose-level, the duration of the period of drug administration, and the pharmacokinetics and metabolism in a given species. For example, in our experience the rat is less tolerant of NSAID than is the monkey, and the dog is less tolerant than the rat. Gastrointestinal lesions have been seen following both parenteral and oral administration; these findings suggest that factors other than local irritation play a role in the development of lesions. Most NSAID inhibit prostaglandin cyclo-oxygenase activity, which results in a prostaglandin deficiency at the tissue level. The administration of relevant exogenous prostaglandins, such as 16,16-dimethyl PGE,, has been shown to inhibit the gastrointestinal toxicity accompanying the administration of several NSAID, including some of the propionic acids.
INTRODUCTION
Despite years of work in search of a more appropriate agent, aspirin (acetyl salicylic acid or ASA) is regarded by many as the reference standard for use in human inflammatory disease. ASA is efficacious (3) and inexpensive, but it also has liabilities. These liabilities, including gastrointestinal intolerance and irritation (6, 8) , have led to the development of the numerous nonsteroidal anti-inflammatory drugs (NSAID) that are either available, or under evaluation, today. However, many of these M A I D also have liabilities, including gastrointestinal irritation. This paper will explore certain aspects of gastrointestinal toxicity as it occurs in laboratory species following the administration of several of the propionic acid group of NSAID. The compounds to be discussed include fenoprofen, naproxen, flurbiprofen, and ibuprofen, with the emphasis on the latter two. Reference will also be made to ketoprofen, a member of the propionic acid class marketed for several years in other countries, and more recently in the United States. Chemical structures are shown in Fig. 1 . Four of the compounds are racemic mixtures, while the fifth, naproxen, is an enantiomer. Most of the information presented is based on observations made during routine toxicity studies and is, in general, common knowledge to the extent that most NSAID are potential gastrointestinal irritants. In days. OBSERVATIONS Table I shows results from routine single-dose, oral studies conducted in rats given fenoprofen, naproxen, flurbiprofen and ibuprofen. Compounds were administered as suspensions in 0.25% methylcellulose following overnight fasting. Water was allowed ad libittun. From the table it is apparent that abdominal adhesions and other indicators of a peritonitis were seen in animals given each of the four compounds and that deaths occurred during the same general time period. The necrotic foci were typically yellow and were found in the wall of the jejunum and ileum. It is interesting that gastric lesions were not apparent, since all four compounds have been shown to produce gastric toxicity experimentally (6, 8) . The fact that food was made available shortly after drug administration and the possibility that the stomachs may not have been completely empty at the time ofdrug administration may have been causative factors. It also has been suggested that high doses of imtant agents, such as the doses shown in Table I , may stimulate gastric mucus production and thereby protect against mucosal injury (I 0). Ketoprofen has been described as being similarly ulcerogenic in laboratory animals (4, 9) .
Our own experience, as well as the work of others (2,7), has shown that the same types of lesions occur whether these compounds are given orally or parenterally. The results ofthe intraperitoneal injection of flurbiprofen and ibuprofen in rats are displayed in Table 11 . It is obvious that although the dose levels are somewhat different from those shown in Table I , the types of lesions recorded are similar.
In acute studies in the rat in which the effects of intravenous administration of ibuprofen on the stomach were compared with the effects of oral administration, the oral route was shown to be more ulcerogenic than the intravenous route (2). The same was true for the intestine. It should be noted that the authors used what they termed "ulcerogenic" doses with respect to the route of administration employed. We have no work which can be compared directly with this study. However, when ibuprofen was given intravenously to nonfasted rats at levels of approximately 135,270 and 530 mg/kg (divided into four equal doses and given at 6-hour intervals over a single 24-hour period), both gastric ( Fig. 2) and intestinal (Fig. 3) ulcers and/or erosions were seen in the two higher dose groups (Table 111 ). In some rats, the lesions were shallow and had accompanying hemorrhages. In others they extended into the submucosa, with many inflammatory cells at their bases and some inflammatory cells in the deeper tissues. By way of contrast, single oral doses of ibuprofen in fasted rats at levels under 500 mgkg were free of macroscopic gastrointestinal changes.
Most of our nonrodent toxicity studies with drugs of the propionic acid class have been conducted in the monkey. We have given ibuprofen in daily oral doses of up to 300 mg/kg per day (in 3 equal doses during the normal working day) for 90 days with Fig. 4 ). When given intravenously for 14 days under the same 24-hour dosing conditions described above, monkeys given both 100 and 200 mdkg per 24 hours had stomach and/or duodenal ulcers ( Table V) . The duodenal ulcers were located close to the pyloric sphincter, were approximately 1.5-2.0 cm in diameter, and generally were deep (Fig. 5) . Frequently, there were inflammatory cells in the muscle layer with numerous inflammatory cells along the serosal surface.
Results of the chronic oral administration offiurbiprofen to rats are shown in Table VI . Gastric ulcerations and/or erosions were seen in both 3-month and 2-year studies. Relatively few intestinal lesions were noted, contrary to what one might expect in long term studies. Fig. 6 is a photomicrograph of a typical gastric ulcer from a rat which lived for the duration of the 2-year study. 
DISCUSSION
We have not used the dog to any extent in our toxicologic evaluation of members of the propionic acid class of NSAID. It is well-recognized that this species is particularly sensitive to the ulcerogenic activity of anti-inflammatory compounds (5), including ibuprofen (1) . Single oral doses above 125 mg/kg and repeated oral doses of 8 and 16 mg/kg for 30 days were accompanied by ulcers or erosions in the gastric antrum or pylorus. The reason for the sensitivity to ibuprofen of the dog gastrointestinal tract, in contrast to that ofthe rat, probably is related to the fact that in the dog, plasma levels remain high for a much longer period of time than in the rat (1). Flurbiprofen is somewhat similar; the plasma halflife is approximately 35-40 hours in the dog, whereas it is on the order of 1.5-3 hours in the monkey and 3-6 hours in the rat (12) .
It would appear that a major reason for the gastrointestinal toxicity seen in laboratory species following the administraiton of NSAID is tied in with the ability of NSAID to inhibit prostaglandin synthesis. That this applies to members ofthe propionic acid class as well as to other NSAID (1 1) is indicated by the fact that the concurrent administration of several of the prostaglandins has been shown to inhibit the ulcerogenic activity of several of these agents. To state that the inhibition of prostaglandin synthesis in the gastrointestinal tract is the mechanism through which propionic acid (and other) NSAID produce gastrointestinal irritation probably is an over-simplification. Although much has been learned, much still remains to be learned about local conditions in the gastrointestinal tract in the prostaglandin-deficient state.
